A minoglycosides are widely used for the treatment of various bacterial infections due to Gram-positive and Gram-negative bacteria. Resistance to these antibiotics is frequently mediated by modifying enzymes that are able to acetylate, phosphorylate or adenylate the antibiotic molecule (1) . Recently, 16S rRNA methyltransferases (ArmA, RmtA to -F, and NmpA) have been described as a new high-level aminoglycoside resistance mechanism among Gram-negative pathogenic bacteria (2, 3, 4) . Since 2003, these methyltransferases have been reported worldwide, usually from human clinical isolates, except for ArmA and RmtB, reported from chickens (5) and pigs (6, 7, 8) , and ArmA and RmtC, reported from food isolates (9, 10) . There was no report of a 16S rRNA methyltransferase in bacteria isolated from house pets until 2011, when RmtB was found in several Enterobacteriaceae collected from pets in China (11) .
The aim of this study was to find the genetic determinant responsible for the high-level resistance to clinically important aminoglycosides, such as gentamicin and amikacin, in seven Klebsiella pneumoniae strains isolated from pets (dogs and cats) at the Faculty of Veterinary Medicine in Madrid, Spain. Strains were collected throughout 2008, 2009, and 2010 from different animals with diverse diseases, all referred from the same veterinary surgery (Table 1) . Pulsed-field gel electrophoresis (PFGE) typing was performed with all isolates (9) and showed a high genetic relatedness between them. K. pneumoniae multilocus sequence typing (MLST) was performed by using the primers described by Diancourt et al. (12) except for a different rpoB-forward primer (5=-TCTGACCCGTGAGCGCGCAGGCT). Allelic profiles and sequence types (STs) were verified at http://www.pasteur .fr/recherche/genopole/PF8/mlst/Kpneumoniae.html. A unique allelic profile was obtained with the seven isolates, corresponding to ST11. ST11 is an epidemic clone of K. pneumoniae that has been isolated from humans worldwide, and it is associated with the spread of resistance determinants such as OXA-48 or NDM (13, 14, 15) . The MICs, determined and interpreted according to Clinical and Laboratory Standards Institute guidelines (16, 17) , showed high-level resistance to all 4,6-disubstituted 2-deoxystreptamine aminoglycosides, as well as to ampicillin, ceftazidime, sulfamethoxazole, tetracycline, chloramphenicol, and fluoroquinolones ( Table 2) .
Screening of 16S rRNA methyltransferase-encoding genes was performed by PCR and sequencing (9) , revealing the presence of the armA gene in the seven isolates. Transfer of this gene into a laboratory Escherichia coli INVF= strain was carried out by transformation using plasmid DNA extraction (Plasmid Midi Kit; Qiagen, Inc., Chatworth, CA) and demonstrated that armA was borne by a plasmid in all the K. pneumoniae strains. In order to elucidate ␤-lactam and quinolone resistance determinants, multiplex PCR assays for TEM, SHV, CMY, DHA, and Qnr genes were performed with wild-type and transformant bacteria (18, 19) . bla SHV-11 was identified in the seven K. pneumoniae isolates, although it was absent in the corresponding transformants. A bla DHA gene was amplified in the seven wild-type isolates and their transformants, and it was confirmed by sequencing to be bla DHA-1 . The bla DHA-1 gene was coharbored by the same plasmid as armA in the seven K. pneumoniae isolates. A qnrB4 gene was detected in the wild-type strains, and it was found with armA and bla DHA-1 in the same plasmid in five strains (BB1097, BB1099, BB1101, BB1102, and BB1103) (Table (Table 1) carried these genes on a genetic structure identical to that present in pKP048 (Fig. 1) . However, pKP048 is an IncF plasmid of 150 kb in size, whereas S1 nuclease digestion (Promega, Madison, WI) and PFGE of the wild-type strains and transformants showed that these genes were borne by a plasmid of approximately 50 kb in the seven strains (data not shown). This plasmid was named pB1025, and it was confirmed to belong to the IncR family using a PCR-based replicon typing kit 
FIG 1
Illustration of the 25-kb genetic structure where armA, blaDHA-1, and qnrB4 are embedded in pKP048 and comparison with plasmids pB1025 and pB1025-1. pB1025 has the same genetic structure as pKP048 despite being of a different size and belonging to another Inc family, whereas in pB1025-1, with the same size and Inc group as pB1025, qnrB4 is not located on this genetic structure. The primers are indicated with small arrows: a, 5= TCCAGACGGCCACATT GGAGG; b, 5= TCAAATAGTGTATTTTCAGTG; c, 5= CGATATCATGTTAATGGCTGA; d, 5= GACGCCTTGCAAATCAACCCCG; e, 5= CAGGTTCACCGGT GAAAAAGTT; f, 5= ATCGCTGGCGAAGCAACTGGC.
(Diatheva, Fano, Italy). Interestingly, IncR plasmids have often been associated with human isolates, but to the best of our knowledge they have not been reported from pet animals to date. In strains BB1098 and BB1100, armA and bla DHA-1 are embedded in the same genetic structure as in the other five strains (Fig. 1) . This genetic structure also takes part of an IncR plasmid of 50 kb, most likely a pB1025 derivative that was named pB1025-1, since qnrB4 has a different environment and seems to be borne by a different plasmid. Attempts to conjugate pB1025 and pB1025-1 into a recipient laboratory strain as previously described (9) were unsuccessful. This study describes the occurrence of the ArmA methyltransferase in an ST11 clone of K. pneumoniae isolated from pets in Spain, in association with the resistance genes bla DHA-1 , bla SHV-11 , and qnrB4. This is the first time that armA has been detected in bacteria from pet animals. To the best of our knowledge, this is also the first report of an IncR plasmid in bacteria isolated from pets. Interestingly, several reports from clinical settings point out that K. pneumoniae ST11 is a pathogenic clone adapted to humans and usually produces emerging resistance mechanisms. Thus, this finding is of utmost clinical relevance due to the relationship of pet animals with humans, as it poses a new reservoir for the dissemination of both the ST11 epidemic clone and these resistance genes. Further monitoring of emerging resistance genes in bacteria isolated from pets is essential to minimize their spread between humans and animals.
